Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes

Abstract Background Cardiovascular disease and kidney damage are tightly associated in people with type 2 diabetes. Experimental evidence supports a causal role for vasopressin (or antidiuretic hormone) in the development of diabetic kidney disease (DKD). Plasma copeptin, the COOH-terminal portion o...

Full description

Bibliographic Details
Main Authors: Gilberto Velho, Stéphanie Ragot, Ray El Boustany, Pierre-Jean Saulnier, Mathilde Fraty, Kamel Mohammedi, Frédéric Fumeron, Louis Potier, Michel Marre, Samy Hadjadj, Ronan Roussel
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Cardiovascular Diabetology
Subjects:
Copeptin
Vasopressin
Type 2 diabetes
Cardiovascular disease
Diabetic kidney disease
Epidemiology
Online Access:http://link.springer.com/article/10.1186/s12933-018-0753-5

Internet

http://link.springer.com/article/10.1186/s12933-018-0753-5

Similar Items